MACKENZIE FINANCIAL CORP - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q3 2023$8,351,773
+1203.2%
128,965
+1285.7%
0.01%
+1300.0%
Q2 2023$640,880
-90.9%
9,307
-94.6%
0.00%
-91.7%
Q3 2022$7,020,000
-0.7%
172,049
+33.9%
0.01%
+9.1%
Q2 2022$7,067,000
+544.8%
128,488
+446.6%
0.01%
+1000.0%
Q4 2021$1,096,00023,5080.00%
Other shareholders
LEGEND BIOTECH CORP shareholders Q3 2022
NameSharesValueWeighting ↓
FengHe Fund Management Pte. Ltd. 997,714$36,257,00013.28%
JOHNSON & JOHNSON 1,629,173$59,204,00011.19%
Paradigm Biocapital Advisors LP 831,728$30,225,0007.99%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,100,542$39,994,0005.54%
HHLR ADVISORS, LTD. 6,936,617$252,077,0005.26%
Old Well Partners, LLC 79,700$2,896,0001.94%
Parkman Healthcare Partners LLC 120,473$4,378,0001.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 4,500$5,632,0001.27%
AtonRa Partners 50,928$1,851,0001.00%
Avidity Partners Management LP 1,095,000$39,792,0000.83%
View complete list of LEGEND BIOTECH CORP shareholders